Abiraterone G.L. Pharma (Abiraterone Acetate)

Abiraterone Acetate is a medication used to treat certain types of cancer. This oral medication is manufactured by G.L. Pharma GmbH and is available in the EU market.

Abiraterone Acetate is primarily used in the treatment of prostate cancer. It works by reducing the levels of androgens in the body, which can help slow the growth of cancer cells. This medication is often prescribed as part of a comprehensive treatment plan for advanced prostate cancer.

Common effects of Abiraterone Acetate may include fatigue, joint pain, and swelling. Some users may also experience high blood pressure or low potassium levels. It is important to monitor these effects and consult a healthcare provider if they become severe or persistent.

Abiraterone Acetate should be handled with care and stored according to the manufacturer's instructions. It is important to follow the prescribed dosage and not to exceed it without medical advice. Pregnant women should avoid handling this medication due to potential risks.

Abiraterone Acetate can interact with a variety of medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of this medication.